Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple MyelomaJesús F. San Miguel, Hermann Einsele, Binod Dhakal et al.|New England Journal of Medicine|2023Cited by 719
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trialNathan Fowler, Catherine Thiéblemont, Hideo Harigae et al.|Nature Medicine|2021Cited by 523
NKG2D-CAR-transduced natural killer cells efficiently target multiple myelomaAlejandra Leivas, Joaquín Martínez‐López|Blood Cancer Journal|2021Cited by 137
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myelomaBruno Paiva, Juan‐José Garcés, Gabriel Bretones et al.|Leukemia|2020Cited by 47
Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell LymphomasMiguel Gallardo, Sean M. Post, Prerna Malaney et al.|JNCI Journal of the National Cancer Institute|2019Cited by 43